<?xml version="1.0" encoding="UTF-8"?>
<p id="p0466" num="0466" sourceFile="EP 1828185B1.xml">The title compound was prepared from 
  <i>N</i>-{3-[3-(2-chloro-4-pyrimidinyl)pyrazolo[1,5-a]pyridin-2-yl]phenyl}-2,6-difluorobenzamide and 4-(4-ethyl-1-piperazinyl)aniline in a manner analogous to 
  <b>Example 64</b>. 
  <sup>1</sup>H NMR (400 MHz, DMSO-d
  <sub>6</sub>) δ 1.07 (t, 3H, J = 7.1 Hz), 2.40 (q, 2H, J = 7.1 Hz), 2.53-2.57 (m, 4H overlapping with d
  <sub>6</sub>-DMSO), 3.08-3.11 (m, 4H), 6.52 (d, 1 H, J = 5.2 Hz), 6.86 (d, 2H, J = 9.0 Hz), 7.15 (t, 1 H, J = 5.7 Hz), 7.29 (t, 2H, J = 8.0 Hz), 7.36 (d, 1H, J = 7.8 Hz), 7.46-7.54 (m, 4H), 7.62 (quintet, 1H, J = 8.4 Hz), 7.85 (d, 1H, J = 8.7 Hz), 8.04 (s, 1 H), 8.25 (d, 1H, J = 5.4 Hz), 8.47 (bd, 1 H, J = 8.9 Hz), 8.87 (d, 1H, J = 6.9 Hz), 9.30 (s, 1 H), 10.98 (s, 1 H); ESIMS (M+H)
  <sup>+</sup> = 631.
</p>
